Centogene receives nasdaq notification regarding minimum market value of publicly held shares deficiency

Cambridge, mass. and rostock, germany and berlin, june 14, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg) (“we” or the “company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has received a written notification (the "notification letter") from the nasdaq stock market llc (“nasdaq”) dated june 8, 2023, indicating that the company is not in compliance with the minimum market value of publicly held shares (“mvphs”) set forth in the nasdaq rules for continued listing on the nasdaq global market. nasdaq listing rule 5450(b)(3)(c) requires companies to maintain a minimum mvphs of usd 15 million, and listing rule 5810(c)(3)(d) provides that a failure to meet the mvphs requirement exists if the deficiency continues for a period of 30 consecutive business days. based on the mvphs of the company for the 30 consecutive business days from april 26, 2023 to june 7, 2023, the company no longer meets the mvphs minimum requirement. this notification does not impact the listing and trading of the company's securities at this time.
CNTG Ratings Summary
CNTG Quant Ranking